speb/financial-data huggingface dataset:
EMR.L balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 17200000.00
EMR.L cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -500000.00
EMR.L cash_flow (annual, 2024-12-31) — Change In Payable: -900000.00
EMR.L cash_flow (annual, 2024-12-31) — Change In Receivables: -200000.00
EMR.L cash_flow (annual, 2024-12-31) — Change In Working Capital: -1100000.00
EMR.L cash_flow (annual, 2024-12-31) — Changes In Cash: 500000.00
EMR.L balance_sheet (annual, 2024-12-31) — Common Stock: 2500000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Common Stock: 2500000.00
EMR.L cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -500000.00
EMR.L balance_sheet (annual, 2024-12-31) — Common Stock Equity: 24400000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 24400000.00
EMR.L cash_flow (annual, 2024-12-31) — Common Stock Payments: -200000.00
EMR.L income_statement (annual, 2024-12-31) — Cost Of Revenue: 195800000.00
EMR.L balance_sheet (annual, 2024-12-31) — Current Assets: 56700000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Current Assets: 56700000.00
EMR.L balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 5000000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 5000000.00
EMR.L balance_sheet (annual, 2024-12-31) — Current Debt: 18700000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Current Debt: 18700000.00
EMR.L balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 23700000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 23700000.00
EMR.L balance_sheet (annual, 2024-12-31) — Current Liabilities: 51300000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 51300000.00
EMR.L cash_flow (annual, 2024-12-31) — Deferred Tax: 3700000.00
EMR.L cash_flow (annual, 2024-12-31) — Depreciation: 6800000.00
EMR.L cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 8000000.00
EMR.L income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 1200000.00
EMR.L income_statement (annual, 2024-12-31) — Depreciation Income Statement: 0.00
EMR.L income_statement (annual, 2024-12-31) — Diluted Average Shares: 51100000.00
EMR.L income_statement (annual, 2024-12-31) — Diluted EPS: -0.21
EMR.L income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -10400000.00
EMR.L income_statement (annual, 2024-12-31) — EBIT: -2800000.00
EMR.L income_statement (annual, 2024-12-31) — EBITDA: 5200000.00
EMR.L cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -400000.00
EMR.L cash_flow (annual, 2024-12-31) — End Cash Position: 17200000.00
EMR.L cash_flow (annual, 2024-12-31) — Financing Cash Flow: -900000.00
EMR.L cash_flow (annual, 2024-12-31) — Free Cash Flow: 600000.00
EMR.L cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 600000.00
EMR.L income_statement (annual, 2024-12-31) — General And Administrative Expense: 46600000.00
EMR.L balance_sheet (annual, 2024-12-31) — Goodwill: 26600000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Goodwill: 26600000.00
EMR.L balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 32300000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 32300000.00
EMR.L balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 30300000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 30300000.00
EMR.L balance_sheet (annual, 2024-12-31) — Gross PPE: 31300000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Gross PPE: 31300000.00
EMR.L income_statement (annual, 2024-12-31) — Gross Profit: 50400000.00
EMR.L income_statement (annual, 2024-12-31) — Interest Expense: 2400000.00
EMR.L income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 2400000.00
EMR.L income_statement (annual, 2024-12-31) — Interest Income: 800000.00
EMR.L income_statement (annual, 2024-12-31) — Interest Income Non Operating: 800000.00
EMR.L cash_flow (annual, 2024-12-31) — Interest Paid Cfo: -2400000.00
EMR.L cash_flow (annual, 2024-12-31) — Interest Received Cfi: 800000.00
EMR.L balance_sheet (annual, 2024-12-31) — Invested Capital: 57100000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Invested Capital: 57100000.00
EMR.L cash_flow (annual, 2024-12-31) — Investing Cash Flow: 0.00
EMR.L cash_flow (annual, 2024-12-31) — Issuance Of Debt: 6600000.00
EMR.L balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 1200000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 1200000.00
EMR.L balance_sheet (annual, 2024-12-31) — Long Term Debt: 14000000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 14000000.00
EMR.L balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 15200000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 15200000.00
EMR.L cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 5200000.00
EMR.L cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -100000.00
EMR.L balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 8100000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 8100000.00
EMR.L balance_sheet (annual, 2024-12-31) — Minority Interest: 7000000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Minority Interest: 7000000.00
EMR.L income_statement (annual, 2024-12-31) — Minority Interests: -1500000.00
EMR.L cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
EMR.L cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -200000.00
EMR.L balance_sheet (annual, 2024-12-31) — Net Debt: 15500000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Net Debt: 15500000.00
EMR.L income_statement (annual, 2024-12-31) — Net Income: -10400000.00
EMR.L income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -10400000.00
EMR.L income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -8900000.00
EMR.L income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -10400000.00
EMR.L income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -10400000.00
EMR.L cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -8900000.00
EMR.L income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -8900000.00
EMR.L income_statement (annual, 2024-12-31) — Net Interest Income: -1600000.00
EMR.L cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 5900000.00
EMR.L cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 5100000.00
EMR.L income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -1600000.00
EMR.L balance_sheet (annual, 2024-12-31) — Net PPE: 7500000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Net PPE: 7500000.00
EMR.L cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -800000.00
EMR.L cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 800000.00
EMR.L balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -7900000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -7900000.00
EMR.L balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 4000000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 4000000.00
EMR.L balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 2200000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 2200000.00
EMR.L balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 400000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 400000.00
EMR.L income_statement (annual, 2024-12-31) — Normalized EBITDA: 10300000.00
EMR.L income_statement (annual, 2024-12-31) — Normalized Income: -4650000.00
EMR.L cash_flow (annual, 2024-12-31) — Operating Cash Flow: 1400000.00
EMR.L income_statement (annual, 2024-12-31) — Operating Income: 2600000.00
EMR.L income_statement (annual, 2024-12-31) — Operating Revenue: 246200000.00
EMR.L balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 49051862.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 49051862.00
EMR.L balance_sheet (annual, 2024-12-31) — Other Equity Interest: -10300000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: -10300000.00
EMR.L balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 5700000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 5700000.00
EMR.L cash_flow (annual, 2024-12-31) — Other Non Cash Items: 2000000.00
EMR.L income_statement (annual, 2024-12-31) — Other Operating Expenses: 3200000.00
EMR.L balance_sheet (annual, 2024-12-31) — Other Payable: 1800000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Other Payable: 1800000.00
EMR.L balance_sheet (annual, 2024-12-31) — Other Properties: 2500000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Other Properties: 2500000.00
EMR.L balance_sheet (annual, 2024-12-31) — Other Receivables: 8700000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Other Receivables: 8700000.00
EMR.L income_statement (annual, 2024-12-31) — Other Special Charges: 600000.00
EMR.L income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
EMR.L balance_sheet (annual, 2024-12-31) — Payables: 9600000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Payables: 9600000.00
EMR.L balance_sheet (annual, 2024-12-31) — Prepaid Assets: 700000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 700000.00
EMR.L income_statement (annual, 2024-12-31) — Pretax Income: -5200000.00
EMR.L balance_sheet (annual, 2024-12-31) — Properties: 0.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
EMR.L cash_flow (annual, 2024-12-31) — Purchase Of PPE: -800000.00
EMR.L income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 195800000.00
EMR.L income_statement (annual, 2024-12-31) — Reconciled Depreciation: 8000000.00
EMR.L cash_flow (annual, 2024-12-31) — Repayment Of Debt: -700000.00
EMR.L cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -200000.00
EMR.L income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 1300000.00
EMR.L balance_sheet (annual, 2024-12-31) — Retained Earnings: 8400000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 8400000.00
EMR.L cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
EMR.L income_statement (annual, 2024-12-31) — Selling General And Administration: 46600000.00
EMR.L balance_sheet (annual, 2024-12-31) — Share Issued: 49853001.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Share Issued: 49853001.00
EMR.L cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 1400000.00
EMR.L cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -600000.00
EMR.L income_statement (annual, 2024-12-31) — Special Income Charges: -6200000.00
EMR.L cash_flow (annual, 2024-12-31) — Stock Based Compensation: 100000.00
EMR.L balance_sheet (annual, 2024-12-31) — Stockholders Equity: 24400000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 24400000.00
EMR.L balance_sheet (annual, 2024-12-31) — Tangible Book Value: -7900000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -7900000.00
EMR.L income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -1550000.00
EMR.L income_statement (annual, 2024-12-31) — Tax Provision: 3700000.00
EMR.L income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.25
EMR.L balance_sheet (annual, 2024-12-31) — Taxes Receivable: 400000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 400000.00
EMR.L cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -2100000.00
EMR.L balance_sheet (annual, 2024-12-31) — Total Assets: 100500000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Total Assets: 100500000.00
EMR.L balance_sheet (annual, 2024-12-31) — Total Capitalization: 38400000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 38400000.00
EMR.L balance_sheet (annual, 2024-12-31) — Total Debt: 38900000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Total Debt: 38900000.00
EMR.L balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 31400000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 31400000.00
EMR.L income_statement (annual, 2024-12-31) — Total Expenses: 243600000.00
EMR.L balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 69100000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 69100000.00
EMR.L balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 43800000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 43800000.00
EMR.L balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 17800000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 17800000.00
EMR.L income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -3600000.00
EMR.L balance_sheet (annual, 2024-12-31) — Total Tax Payable: 5800000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 5800000.00
EMR.L income_statement (annual, 2024-12-31) — Total Unusual Items: -5100000.00
EMR.L income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -6200000.00
EMR.L balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 801139.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 801139.00
EMR.L balance_sheet (annual, 2024-12-31) — Working Capital: 5400000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Working Capital: 5400000.00
EMR.L income_statement (annual, 2024-12-31) — Write Off: 3200000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1900000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 28100000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 22400000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -600000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 4200000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2500000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 15600000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 15600000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Common Stock: 2500000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 21700000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Current Assets: 55400000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 3000000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Current Debt: 16900000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 19900000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 49900000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Goodwill: 26700000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 31600000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 28700000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Gross PPE: 5400000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Invested Capital: 53600000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1200000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 15000000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 16200000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Minority Interest: 6900000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Net Debt: 16300000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Net PPE: 5400000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -9900000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 4300000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 2000000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 49051862.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 4900000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Other Payable: 4400000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Other Properties: 5400000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Other Receivables: 9800000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Payables: 12500000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 1500000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 7000000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Share Issued: 49051862.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 21700000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -9900000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 400000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Total Assets: 96700000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 36700000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Total Debt: 36100000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 28600000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 68100000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 41300000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 18200000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 6200000.00
EMR.L balance_sheet (quarterly, 2025-06-30) — Working Capital: 5500000.00
EMR.L income_statement (annual, 2025-12-31) — +Operating Expense: 42700000.00
EMR.L income_statement (annual, 2025-12-31) — +Total Revenue: 239000000.00
EMR.L balance_sheet (annual, 2025-12-31) — Accounts Payable: 2500000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2500000.00
EMR.L balance_sheet (annual, 2025-12-31) — Accounts Receivable: 29500000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 29500000.00
EMR.L balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -25900000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -25900000.00
EMR.L balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 22400000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 22400000.00
EMR.L balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -500000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -500000.00
EMR.L income_statement (annual, 2025-12-31) — Amortization: 1100000.00
EMR.L cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 1100000.00
EMR.L income_statement (annual, 2025-12-31) — Basic Average Shares: 49100000.00
EMR.L income_statement (annual, 2025-12-31) — Basic EPS: -0.19
EMR.L cash_flow (annual, 2025-12-31) — Beginning Cash Position: 17200000.00
EMR.L balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 23300000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 23300000.00
EMR.L cash_flow (annual, 2025-12-31) — Capital Expenditure: -1000000.00
EMR.L balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 6600000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 6600000.00
EMR.L balance_sheet (annual, 2025-12-31) — Capital Stock: 2500000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2500000.00
EMR.L balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 17600000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 17600000.00
EMR.L balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 17600000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 17600000.00
EMR.L cash_flow (annual, 2025-12-31) — Change In Payable: 2300000.00
EMR.L cash_flow (annual, 2025-12-31) — Change In Receivables: 700000.00
EMR.L cash_flow (annual, 2025-12-31) — Change In Working Capital: 3000000.00
EMR.L cash_flow (annual, 2025-12-31) — Changes In Cash: 1800000.00
EMR.L balance_sheet (annual, 2025-12-31) — Common Stock: 2500000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Common Stock: 2500000.00
EMR.L cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: 0.00
EMR.L balance_sheet (annual, 2025-12-31) — Common Stock Equity: 13700000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 13700000.00
EMR.L cash_flow (annual, 2025-12-31) — Common Stock Payments: -200000.00
EMR.L income_statement (annual, 2025-12-31) — Cost Of Revenue: 191700000.00
EMR.L balance_sheet (annual, 2025-12-31) — Current Assets: 58200000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Current Assets: 58200000.00
EMR.L balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 5400000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 5400000.00
EMR.L balance_sheet (annual, 2025-12-31) — Current Debt: 34900000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Current Debt: 34900000.00
EMR.L balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 40300000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 40300000.00
EMR.L balance_sheet (annual, 2025-12-31) — Current Liabilities: 71700000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 71700000.00
EMR.L cash_flow (annual, 2025-12-31) — Deferred Tax: 3200000.00
EMR.L cash_flow (annual, 2025-12-31) — Depreciation: 6400000.00
EMR.L cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 7500000.00
EMR.L income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 1100000.00
EMR.L income_statement (annual, 2025-12-31) — Depreciation Income Statement: 0.00
EMR.L income_statement (annual, 2025-12-31) — Diluted Average Shares: 49900000.00
EMR.L income_statement (annual, 2025-12-31) — Diluted EPS: -0.19
EMR.L income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -9300000.00
EMR.L income_statement (annual, 2025-12-31) — EBIT: -2000000.00
EMR.L income_statement (annual, 2025-12-31) — EBITDA: 5500000.00
EMR.L cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -1400000.00
EMR.L cash_flow (annual, 2025-12-31) — End Cash Position: 17600000.00
EMR.L cash_flow (annual, 2025-12-31) — Financing Cash Flow: -5600000.00
EMR.L cash_flow (annual, 2025-12-31) — Free Cash Flow: 6700000.00
EMR.L cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
EMR.L income_statement (annual, 2025-12-31) — General And Administrative Expense: 41600000.00
EMR.L balance_sheet (annual, 2025-12-31) — Goodwill: 21600000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Goodwill: 21600000.00
EMR.L balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 25900000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 25900000.00
EMR.L balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 30000000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 30000000.00
EMR.L balance_sheet (annual, 2025-12-31) — Gross PPE: 33700000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Gross PPE: 33700000.00
EMR.L income_statement (annual, 2025-12-31) — Gross Profit: 47300000.00
EMR.L income_statement (annual, 2025-12-31) — Interest Expense: 2400000.00
EMR.L income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 2400000.00
EMR.L income_statement (annual, 2025-12-31) — Interest Income: 700000.00
EMR.L income_statement (annual, 2025-12-31) — Interest Income Non Operating: 700000.00
EMR.L cash_flow (annual, 2025-12-31) — Interest Paid Cfo: -2400000.00
EMR.L cash_flow (annual, 2025-12-31) — Interest Received Cfi: 700000.00
EMR.L balance_sheet (annual, 2025-12-31) — Invested Capital: 48600000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Invested Capital: 48600000.00
EMR.L cash_flow (annual, 2025-12-31) — Investing Cash Flow: -300000.00
EMR.L cash_flow (annual, 2025-12-31) — Issuance Of Debt: 2100000.00
EMR.L balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 1200000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1200000.00
EMR.L balance_sheet (annual, 2025-12-31) — Long Term Debt: 0.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 0.00
EMR.L balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1200000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1200000.00
EMR.L cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 1100000.00
EMR.L cash_flow (annual, 2025-12-31) — Long Term Debt Payments: 0.00
EMR.L balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 8400000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 8400000.00
EMR.L balance_sheet (annual, 2025-12-31) — Minority Interest: 6500000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Minority Interest: 6500000.00
EMR.L income_statement (annual, 2025-12-31) — Minority Interests: -1700000.00
EMR.L cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -200000.00
EMR.L balance_sheet (annual, 2025-12-31) — Net Debt: 17300000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Net Debt: 17300000.00
EMR.L income_statement (annual, 2025-12-31) — Net Income: -9300000.00
EMR.L income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -9300000.00
EMR.L income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -7600000.00
EMR.L income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -9300000.00
EMR.L income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -9300000.00
EMR.L cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -7600000.00
EMR.L income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -7600000.00
EMR.L income_statement (annual, 2025-12-31) — Net Interest Income: -1700000.00
EMR.L cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 1800000.00
EMR.L cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 1100000.00
EMR.L income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1700000.00
EMR.L balance_sheet (annual, 2025-12-31) — Net PPE: 7800000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Net PPE: 7800000.00
EMR.L cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -1000000.00
EMR.L cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 700000.00
EMR.L balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -12200000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -12200000.00
EMR.L balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 3900000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 3900000.00
EMR.L balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2300000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2300000.00
EMR.L balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 400000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 400000.00
EMR.L income_statement (annual, 2025-12-31) — Normalized EBITDA: 7500000.00
EMR.L income_statement (annual, 2025-12-31) — Normalized Income: 1475000.00
EMR.L cash_flow (annual, 2025-12-31) — Operating Cash Flow: 7700000.00
EMR.L income_statement (annual, 2025-12-31) — Operating Income: 4600000.00
EMR.L income_statement (annual, 2025-12-31) — Operating Revenue: 239000000.00
EMR.L balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 49051862.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 49051862.00
EMR.L balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 4300000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 4300000.00
EMR.L cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1700000.00
EMR.L balance_sheet (annual, 2025-12-31) — Other Payable: 1300000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Other Payable: 1300000.00
EMR.L balance_sheet (annual, 2025-12-31) — Other Properties: 2000000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Other Properties: 2000000.00
EMR.L balance_sheet (annual, 2025-12-31) — Other Receivables: 8100000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Other Receivables: 8100000.00
EMR.L income_statement (annual, 2025-12-31) — Other Special Charges: 700000.00
EMR.L income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
EMR.L balance_sheet (annual, 2025-12-31) — Payables: 11900000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Payables: 11900000.00
EMR.L balance_sheet (annual, 2025-12-31) — Prepaid Assets: 600000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 600000.00
EMR.L income_statement (annual, 2025-12-31) — Pretax Income: -4400000.00
EMR.L balance_sheet (annual, 2025-12-31) — Properties: 0.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
EMR.L cash_flow (annual, 2025-12-31) — Purchase Of PPE: -1000000.00
EMR.L income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 191700000.00
EMR.L income_statement (annual, 2025-12-31) — Reconciled Depreciation: 7500000.00
EMR.L cash_flow (annual, 2025-12-31) — Repayment Of Debt: -300000.00
EMR.L cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -200000.00
EMR.L income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 1300000.00
EMR.L balance_sheet (annual, 2025-12-31) — Retained Earnings: -900000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -900000.00
EMR.L income_statement (annual, 2025-12-31) — Selling General And Administration: 41600000.00
EMR.L balance_sheet (annual, 2025-12-31) — Share Issued: 49853001.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Share Issued: 49853001.00
EMR.L cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 1000000.00
EMR.L cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -300000.00
EMR.L income_statement (annual, 2025-12-31) — Special Income Charges: -7300000.00
EMR.L cash_flow (annual, 2025-12-31) — Stock Based Compensation: 0.00
EMR.L balance_sheet (annual, 2025-12-31) — Stockholders Equity: 13700000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 13700000.00
EMR.L balance_sheet (annual, 2025-12-31) — Tangible Book Value: -12200000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -12200000.00
EMR.L income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -1825000.00
EMR.L income_statement (annual, 2025-12-31) — Tax Provision: 3200000.00
EMR.L income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.25
EMR.L balance_sheet (annual, 2025-12-31) — Taxes Receivable: 2400000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 2400000.00
EMR.L cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -3000000.00
EMR.L balance_sheet (annual, 2025-12-31) — Total Assets: 95800000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Total Assets: 95800000.00
EMR.L balance_sheet (annual, 2025-12-31) — Total Capitalization: 13700000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 13700000.00
EMR.L balance_sheet (annual, 2025-12-31) — Total Debt: 41500000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Total Debt: 41500000.00
EMR.L balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 20200000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 20200000.00
EMR.L income_statement (annual, 2025-12-31) — Total Expenses: 234400000.00
EMR.L balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 75600000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 75600000.00
EMR.L balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 37600000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 37600000.00
EMR.L balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3900000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3900000.00
EMR.L income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -2700000.00
EMR.L balance_sheet (annual, 2025-12-31) — Total Tax Payable: 8100000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 8100000.00
EMR.L income_statement (annual, 2025-12-31) — Total Unusual Items: -2000000.00
EMR.L income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -7300000.00
EMR.L balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 801139.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 801139.00
EMR.L balance_sheet (annual, 2025-12-31) — Working Capital: -13500000.00
EMR.L balance_sheet (quarterly, 2025-12-31) — Working Capital: -13500000.00
EMR.L income_statement (annual, 2025-12-31) — Write Off: 0.00
EMR.V balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 29834.00
EMR.V balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 32051.00
EMR.V cash_flow (annual, 2021-12-31) — Cash Dividends Paid: 0.00
EMR.V balance_sheet (annual, 2021-12-31) — Cash Financial: 357312.00
EMR.V balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 15264.00
EMR.V balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 15264.00
EMR.V balance_sheet (annual, 2021-12-31) — Duefrom Related Parties Current: 0.00
EMR.V cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -1803956.00
EMR.V income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 0.00
EMR.V income_statement (annual, 2021-12-31) — Interest Income: 12303.00
EMR.V income_statement (annual, 2021-12-31) — Interest Income Non Operating: 12303.00
EMR.V cash_flow (annual, 2021-12-31) — Interest Paid Cff: -4018.00
EMR.V balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 16787.00
EMR.V balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 16787.00
EMR.V cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -10888.00
EMR.V cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: 382849.00
EMR.V cash_flow (annual, 2021-12-31) — Net Other Financing Charges: 67743.00
EMR.V balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 122820.00
EMR.V balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 438668.00
EMR.V balance_sheet (annual, 2021-12-31) — Other Non Current Assets: 2148.00
EMR.V income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 120142.00
EMR.V balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 84320.00
EMR.V cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 0.00
EMR.V cash_flow (annual, 2021-12-31) — Repayment Of Debt: -10888.00
EMR.V cash_flow (annual, 2021-12-31) — Sale Of Investment: 382849.00
EMR.V cash_flow (annual, 2021-12-31) — Sale Of PPE: 10000.00
EMR.V income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 202299.00
EMR.V balance_sheet (annual, 2021-12-31) — Total Debt: 32051.00
EMR.V income_statement (annual, 2021-12-31) — Total Operating Income As Reported: -2341988.00
EMR.V income_statement (annual, 2022-12-31) — +Operating Expense: 2293395.00
EMR.V income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
EMR.V balance_sheet (annual, 2022-12-31) — Accounts Payable: 1030081.00
EMR.V balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -107084.00
EMR.V cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
EMR.V income_statement (annual, 2022-12-31) — Basic Average Shares: 17915577.00
EMR.V income_statement (annual, 2022-12-31) — Basic EPS: -0.09
EMR.V cash_flow (annual, 2022-12-31) — Beginning Cash Position: 357312.00
EMR.V balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 29834.00
EMR.V cash_flow (annual, 2022-12-31) — Capital Expenditure: -49555.00
EMR.V balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 16842.00
EMR.V balance_sheet (annual, 2022-12-31) — Capital Stock: 48838993.00
EMR.V balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 688124.00
EMR.V balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 910277.00
EMR.V cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
EMR.V balance_sheet (annual, 2022-12-31) — Cash Financial: 688124.00
EMR.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 1751777.00
EMR.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 732703.00
EMR.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -2125806.00
EMR.V cash_flow (annual, 2022-12-31) — Change In Account Payable: 191400.00
EMR.V cash_flow (annual, 2022-12-31) — Change In Payable: 226485.00
EMR.V cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 226485.00
EMR.V cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -104996.00
EMR.V cash_flow (annual, 2022-12-31) — Change In Receivables: -46134.00
EMR.V cash_flow (annual, 2022-12-31) — Change In Working Capital: 75355.00
EMR.V cash_flow (annual, 2022-12-31) — Changes In Cash: 358674.00
EMR.V balance_sheet (annual, 2022-12-31) — Common Stock: 48838993.00
EMR.V balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1343560.00
EMR.V cash_flow (annual, 2022-12-31) — Common Stock Issuance: 1770022.00
EMR.V income_statement (annual, 2022-12-31) — Cost Of Revenue: 26751.00
EMR.V balance_sheet (annual, 2022-12-31) — Current Assets: 1245663.00
EMR.V balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 16842.00
EMR.V balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 16842.00
EMR.V balance_sheet (annual, 2022-12-31) — Current Liabilities: 2612778.00
EMR.V cash_flow (annual, 2022-12-31) — Depreciation: 26751.00
EMR.V cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 26751.00
EMR.V cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 26751.00
EMR.V income_statement (annual, 2022-12-31) — Diluted Average Shares: 17915577.00
EMR.V income_statement (annual, 2022-12-31) — Diluted EPS: -0.09
EMR.V income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -1570883.00
EMR.V balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 85438.00
EMR.V income_statement (annual, 2022-12-31) — EBIT: -1567038.00
EMR.V income_statement (annual, 2022-12-31) — EBITDA: -1540287.00
EMR.V cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -27862.00
EMR.V cash_flow (annual, 2022-12-31) — End Cash Position: 688124.00
EMR.V cash_flow (annual, 2022-12-31) — Financing Cash Flow: 1751777.00
EMR.V cash_flow (annual, 2022-12-31) — Free Cash Flow: -2175361.00
EMR.V cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -172143.00
EMR.V income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 693271.00
EMR.V income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -15292.00
EMR.V income_statement (annual, 2022-12-31) — General And Administrative Expense: 658404.00
EMR.V balance_sheet (annual, 2022-12-31) — Gross PPE: 2703567.00
EMR.V income_statement (annual, 2022-12-31) — Gross Profit: -26751.00
EMR.V income_statement (annual, 2022-12-31) — Insurance And Claims: 32631.00
EMR.V income_statement (annual, 2022-12-31) — Interest Expense: 3845.00
EMR.V income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 3845.00
EMR.V income_statement (annual, 2022-12-31) — Interest Income: 0.00
EMR.V income_statement (annual, 2022-12-31) — Interest Income Non Operating: 0.00
EMR.V cash_flow (annual, 2022-12-31) — Interest Paid Cff: -3845.00
EMR.V balance_sheet (annual, 2022-12-31) — Invested Capital: 1343560.00
EMR.V cash_flow (annual, 2022-12-31) — Investing Cash Flow: 732703.00
EMR.V cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 1770022.00
EMR.V cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
EMR.V balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 0.00
EMR.V cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -18245.00
EMR.V balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 95012.00
EMR.V cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 1770022.00
EMR.V cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 108435.00
EMR.V income_statement (annual, 2022-12-31) — Net Income: -1570883.00
EMR.V income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -1570883.00
EMR.V income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -1570883.00
EMR.V income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -1570883.00
EMR.V income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -1570883.00
EMR.V cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -1570883.00
EMR.V income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -1570883.00
EMR.V income_statement (annual, 2022-12-31) — Net Interest Income: -8079.00
EMR.V cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 188465.00
EMR.V cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -18245.00
EMR.V cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -18245.00
EMR.V income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -8079.00
EMR.V cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 10000.00
EMR.V balance_sheet (annual, 2022-12-31) — Net PPE: 2596483.00
EMR.V cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 534238.00
EMR.V cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
EMR.V balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1343560.00
EMR.V balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 114192.00
EMR.V income_statement (annual, 2022-12-31) — Normalized EBITDA: -2218266.00
EMR.V income_statement (annual, 2022-12-31) — Normalized Income: -2248862.00
EMR.V cash_flow (annual, 2022-12-31) — Operating Cash Flow: -2125806.00
EMR.V cash_flow (annual, 2022-12-31) — Operating Gains Losses: -688045.00
EMR.V income_statement (annual, 2022-12-31) — Operating Income: -2320146.00
EMR.V income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
EMR.V balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 27170337.00
EMR.V balance_sheet (annual, 2022-12-31) — Other Current Assets: -118.00
EMR.V balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 1480417.00
EMR.V balance_sheet (annual, 2022-12-31) — Other Equity Interest: 8880647.00
EMR.V income_statement (annual, 2022-12-31) — Other Gand A: 602189.00
EMR.V income_statement (annual, 2022-12-31) — Other Income Expense: 757342.00
EMR.V cash_flow (annual, 2022-12-31) — Other Non Cash Items: -48943.00
EMR.V balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 2148.00
EMR.V income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 79363.00
EMR.V income_statement (annual, 2022-12-31) — Other Operating Expenses: 1634991.00
EMR.V balance_sheet (annual, 2022-12-31) — Other Properties: 2608555.00
EMR.V balance_sheet (annual, 2022-12-31) — Other Receivables: 77000.00
EMR.V balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 222153.00
EMR.V income_statement (annual, 2022-12-31) — Other Taxes: 0.00
EMR.V balance_sheet (annual, 2022-12-31) — Payables: 1115519.00
EMR.V balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1115519.00
EMR.V balance_sheet (annual, 2022-12-31) — Prepaid Assets: 149504.00
EMR.V income_statement (annual, 2022-12-31) — Pretax Income: -1570883.00
EMR.V cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
EMR.V cash_flow (annual, 2022-12-31) — Purchase Of PPE: -49555.00
EMR.V balance_sheet (annual, 2022-12-31) — Receivables: 186000.00
EMR.V income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 26751.00
EMR.V income_statement (annual, 2022-12-31) — Reconciled Depreciation: 26751.00
EMR.V income_statement (annual, 2022-12-31) — Rent And Landing Fees: 23584.00
EMR.V income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 23584.00
EMR.V cash_flow (annual, 2022-12-31) — Repayment Of Debt: -18245.00
EMR.V balance_sheet (annual, 2022-12-31) — Retained Earnings: -56376080.00
EMR.V income_statement (annual, 2022-12-31) — Salaries And Wages: 0.00
EMR.V cash_flow (annual, 2022-12-31) — Sale Of Investment: 188465.00
EMR.V cash_flow (annual, 2022-12-31) — Sale Of PPE: 583793.00
EMR.V income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 151271.00
EMR.V income_statement (annual, 2022-12-31) — Selling General And Administration: 658404.00
EMR.V balance_sheet (annual, 2022-12-31) — Share Issued: 27170337.00
EMR.V cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
EMR.V income_statement (annual, 2022-12-31) — Special Income Charges: 693271.00
EMR.V cash_flow (annual, 2022-12-31) — Stock Based Compensation: 0.00
EMR.V balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1343560.00
EMR.V balance_sheet (annual, 2022-12-31) — Tangible Book Value: 1343560.00
EMR.V income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
EMR.V income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
EMR.V balance_sheet (annual, 2022-12-31) — Taxes Receivable: 109000.00
EMR.V balance_sheet (annual, 2022-12-31) — Total Assets: 3956338.00
EMR.V balance_sheet (annual, 2022-12-31) — Total Capitalization: 1343560.00
EMR.V balance_sheet (annual, 2022-12-31) — Total Debt: 16842.00
EMR.V balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1343560.00
EMR.V income_statement (annual, 2022-12-31) — Total Expenses: 2320146.00
EMR.V balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 2612778.00
EMR.V balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 2710675.00
EMR.V balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
EMR.V income_statement (annual, 2022-12-31) — Total Other Finance Cost: 4234.00
EMR.V income_statement (annual, 2022-12-31) — Total Unusual Items: 677979.00
EMR.V income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 677979.00
EMR.V cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 79959.00
EMR.V balance_sheet (annual, 2022-12-31) — Working Capital: -1367115.00
EMR.V income_statement (annual, 2022-12-31) — Write Off: 0.00
EMR.V income_statement (annual, 2023-12-31) — +Operating Expense: 1929692.00
EMR.V income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
EMR.V balance_sheet (annual, 2023-12-31) — Accounts Payable: 1336717.00
EMR.V balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -116555.00
EMR.V cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 77824.00
EMR.V income_statement (annual, 2023-12-31) — Basic Average Shares: 27776214.00
EMR.V income_statement (annual, 2023-12-31) — Basic EPS: -0.03
EMR.V cash_flow (annual, 2023-12-31) — Beginning Cash Position: 688124.00
EMR.V cash_flow (annual, 2023-12-31) — Capital Expenditure: -52974.00
EMR.V balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 0.00
EMR.V balance_sheet (annual, 2023-12-31) — Capital Stock: 49111305.00
EMR.V balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 224525.00
EMR.V balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 224525.00
EMR.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 439663.00
EMR.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 194779.00
EMR.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -1098341.00
EMR.V cash_flow (annual, 2023-12-31) — Change In Account Payable: 306636.00
EMR.V cash_flow (annual, 2023-12-31) — Change In Payable: 454236.00